RE:Clinical TrialsWe need a deal - true!
We just hired the guy who will get us a deal (on PD) IMO. Now, even in the backwoods of Canada, I expect that getting a deal would have a positive effect on the share price but I ask you - would the positive effect be greater if PMN was listed on the NASDAQ?
In your post to me (a few posts back) you mentioned that PMN has been putting out RAH RAH scientific updates for so long that the market has become bored with them and will no longer respond and that they need to put out something different. Announcing that we poached a VP from Pfizer should count as something different and I believe that if we were trading on the NASDAQ that this would have been seen as a significant step forward instead of how it was perceived on the TSX - just another day.